RESPIRATORY TRACT DISEASE
Clinical trials for RESPIRATORY TRACT DISEASE explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY TRACT DISEASE trials appear
Sign up with your email to follow new studies for RESPIRATORY TRACT DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Placenta cells tested as COVID fighter – but trial stopped early
Disease control TerminatedThis early-phase trial tested a new therapy called CYNK-001, which uses natural killer cells from the placenta to fight COVID-19. It enrolled only 7 adults with moderate COVID-19. The study was terminated early, so we have limited information on safety and effectiveness.
Matched conditions: RESPIRATORY TRACT DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Targeted pill shows promise for rare lung cancer, but trial stopped early
Disease control TerminatedThis phase 3 study tested a new drug called pralsetinib against standard chemotherapy for people with a specific type of advanced lung cancer that has a RET gene fusion. The goal was to see if pralsetinib could better delay cancer growth. The trial was terminated early, so full r…
Matched conditions: RESPIRATORY TRACT DISEASE
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC